Other UA molecular targets reported for the treatment of cancer include its effect on p53 pathways [87,88,89,90]; the canonical pathway (Wnt/β-catenin) [91,92]; Ras signaling [93]; and transcription pathways like nuclear factor kappa light chain enhancer of activated B cells (NF-Kb) [94], Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) [95], and the Signal transducer and activator of transcription 3 (STAT3) family of transcription factors [96,97,98]. The gene discussed is NFKB1; the disease is cancer.